Journal of Renal Nutrition
Volume 18, Issue 5 , Pages 440-447, September 2008

Long-Term Effect of a Chicken-Based Diet Versus Enalapril on Albuminuria in Type 2 Diabetic Patients With Microalbuminuria

Division of Endocrinology, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil

Objective

In short-term studies, the replacement of red meat in the diet with chicken reduced the urinary albumin excretion rate (UAER) and improved lipid profile in type 2 diabetic patients with diabetic nephropathy. The present study sought to assess these effects over a long-term period, comparing the effects of a chicken-based diet (CD) versus enalapril on renal function and lipid profile in microalbuminuric type 2 diabetic patients.

Design

This was a randomized, open-label, controlled clinical trial with a follow-up of 1 year.

Setting

The trial involved outpatients with type 2 diabetes attending a clinic of the Division of Endocrinology at a tertiary-care hospital.

Patients

Twenty-eight microalbuminuric patients completed the study and were evaluated.

Interventions

Patients were randomized to an experimental diet (CD plus active placebo) or to treatment with enalapril (10 mg/day plus usual diet).

Main Outcome Measures

The main outcome measure was UAER (according to immunoturbidimetry). Blood pressure, anthropometric indices, and compliance were also evaluated monthly. The glomerular filtration rate (51Cr-EDTA), and lipid, glycemic, and nutritional indices, were measured at baseline and quarterly.

Results

The UAER was reduced after CD (n = 13; from 62.8 [range, 38.4 to 125.1] to 49.1 [range, 6.2 to 146.5] μg/min; P < .001) and after enalapril (n = 15; from 55.8 [range, 22.6 to 194.3] to 23.1 [range, 4.0 to 104.9] μg/min; P < .001), and this was already significant at month 4. The reduction in UAER after CD (32%; 95% confidence interval, 6.7% to 57.6%) and after enalapril treatment (44.7%; 95% confidence interval, 28.3% to 61.1%; P = .366) were not significantly different.

Conclusions

The CD and the angiotensin-converting enzyme inhibitor enalapril promoted a similar reduction of UAER in patients with type 2 diabetes and microalbuminuria in a 12-month follow-up period.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by the Ministério de Ciência e Tecnologia, the Conselho Nacional de Desenvolvimento Científico e Tecnológico (MCT/CNPq 502050/2005-5), and the Fundos de Incentivo a Pesquisa e Eventos-Hospital de Clínicas de Porto Alegre. T.P.P. is a recipient of scholarships from the Fundação Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

PII: S1051-2276(08)00299-9

doi:10.1053/j.jrn.2008.04.010

Journal of Renal Nutrition
Volume 18, Issue 5 , Pages 440-447, September 2008